Differences in drug resistance of HIV-1 genotypes in CSF and plasma and analysis of related factors

References

• Gregson J, Tang M, Ndembi N, et al. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016 May;16(5):1–7. DOI:10.1016/S1473-3099(15)00536-8.
   PubMed Web of Science ®Google Scholar
• Antiviral Response Cohort Analysis (ARCA) Collaborative Group, Rossetti B, Di Giambenedetto S, Torti C, et al. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016. HIV Med. 2018 Oct;19(9):619–628.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Gregson J, Parkin N, et al. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet Infect Dis. 2018 Mar;18(3):346–355.
   PubMed Web of Science ®Google Scholar
• Pang X, Tang K, He Q, et al. HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China. BMC Infect Dis. 2021 Feb 8;21(1):160.
   PubMed Web of Science ®Google Scholar
• Zhao B, Song W, Kang M, et al. Molecular network analysis reveals transmission of HIV-1 drug-resistant strains among newly diagnosed HIV-1 infections in a moderately HIV endemic City in China. Front Microbiol. 2022 Jan 7;12:797771. DOI:10.3389/fmicb.2021.797771.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Kincer LP, Bowman NM, et al. Human immunodeficiency virus type 1 RNA detected in the central nervous system (CNS) after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells. Clin Infect Dis. 2019 Sep 27;69(8):1345–1352.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou T, Zhang Y, et al. The reservoir of latent HIV. Front Cell Infect Microbiol. 2022 Jul 28;12:945956. DOI:10.3389/fcimb.2022.945956.
   PubMed Web of Science ®Google Scholar
• Manesh A, Barnabas R, Mani S, et al. Symptomatic HIV CNS viral escape among patients on effective cART. Int J Infect Dis. 2019 Jul;84:39–43.
   PubMed Web of Science ®Google Scholar
• Lustig G, Cele S, Karim F, et al. T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy. PLOS Pathog. 2021 Sep 23;17(9):e1009871.
   PubMed Web of Science ®Google Scholar
• Di Carlofelice M, Everitt A, Muir D, et al. Cerebrospinal fluid HIV RNA in persons living with HIV. HIV Med. 2018 May;19(5):365–368.
   PubMed Web of Science ®Google Scholar
• Anderson AM, Muñoz-Moreno JA, McClernon DR, et al. CHARTER Group. Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. J Infect Dis. 2017 Jan 1: 215(1):105–113.
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh N, Roda W, Branton WG, et al. Lentiviral infections persist in brain despite effective antiretroviral therapy and neuroimmune activation. MBio. 2021 Dec 21;12(6):e0278421.
   PubMed Web of Science ®Google Scholar
• Menéndez-Arias L. Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses. 2009;1(3):1137–1165.
   PubMed Web of Science ®Google Scholar
• Osborne O, Peyravian N, Nair M, et al. ThE paradox of HIV blood-brain barrier penetrance and antiretroviral drug delivery deficiencies. Trends Neurosci. 2020 Sep;43(9):695–708.
   PubMed Web of Science ®Google Scholar
• Barker CT, Vaidya NK, Regoes RR, et al. Modeling HIV-1 infection in the brain. PLoS Comput Biol. 2020 Nov 19;16(11):e1008305.
   PubMed Web of Science ®Google Scholar
• Lutgen V, Narasipura SD, Barbian HJ, et al. HIV infects astrocytes in vivo and egresses from the brain to the periphery. PLOS Pathog. 2020 Jun 11;16(6):e1008381.
   PubMed Web of Science ®Google Scholar
• Wallet C, De Rovere M, Van Assche J, et al. Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infect Microbiol. 2019 Oct 24;9:362. DOI:10.3389/fcimb.2019.00362.
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV [EB/OL]. 2021-08-162021- 10- 30. https://clinicalinfo.Hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL
   Google Scholar
• European AIDS Clinical Society. EACS guidelines (Version 10.1) [EB/OL]. (2021-07-11) [2021-10-30]. https://www.Eacsociety.org/files/guidelines-10.1_30032021_1.
   Google Scholar
• World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach [M/OL]. (2021-07-16) [2021-10-30]. https://www.Who.int/publications/i/item/9789240031593.
   Google Scholar
• Giacomelli A, Pezzati L, Rusconi S. The crosstalk between antiretrovirals pharmacology and HIV drug resistance. Expert Rev Clin Pharmacol. 2020 Jul;13(7):739–760.
   PubMed Web of Science ®Google Scholar
• McCluskey SM, Siedner MJ, Marconi VC. Management of virologic failure and HIV drug resistance. Infect Dis Clin North Am. 2019 Sep;33(3):707–742.
   PubMed Web of Science ®Google Scholar
• Liang S, Liu Z, Wang S, et al. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017. PLoS ONE. 2020 Dec 21;15(12):e0243650.
   PubMed Web of Science ®Google Scholar
• Mbhele N, Chimukangara B, Gordon M. HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance. Int J Antimicrob Agents. 2021 May;57(5):106343.
   PubMed Web of Science ®Google Scholar
• Ferrara M, Bumpus NN, Ma Q, et al. Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS. 2020 Nov 1;34(13):1907–1914.
   PubMed Web of Science ®Google Scholar
• Asahchop EL, Meziane O, Mamik MK, et al. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain. Retrovirology. 2017 Oct 16;14(1):47.
   PubMedGoogle Scholar
• Mukerji SS, Misra V, Lorenz DR, et al. Impact of antiretroviral regimens on cerebrospinal fluid viral escape in a prospective multicohort study of antiretroviral therapy-experienced human immunodeficiency virus-1-infected adults in the United States. Clin Infect Dis. 2018 Sep 28;67(8):1182–1190.
   PubMed Web of Science ®Google Scholar
• Avedissian SN, Dyavar SR, Fox HS, et al. Pharmacologic approaches to HIV-associated neurocognitive disorders. Curr Opin Pharmacol. 2020 Oct;54:102–108.
   PubMed Web of Science ®Google Scholar